Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegilerdine vs Sufentanil in General Anesthesia Intubation
NCT07323043Recruiting
- Sponsor
- First People's Hospital of Lianyungang City
- Start
- Jan 2026
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of tegilerdine in Adverse reaction to general anesthetic (2 arms), sponsored by First People's Hospital of Lianyungang City. Primary endpoint: Incidence of choking cough response at 2 minutes. Started Jan 2026; status: recruiting.
02
Drugs
tegilerdine
03
Conditions
Adverse reaction to general anesthetic
Beyond the preview
Go deeper on NCT07323043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07323043.